Bioventus has announced the launch of Osteomatrix+, a new biphasic bone graft for use in bone remodeling in many orthopedic and spine applications, according to a company press release.

Osteomatrix+ consists of bovine collagen and biphasic, hydroxyapatite/beta-tricalcium phosphate granules to create a porous scaffold and sustained osteoconductivity throughout the bone remodeling process.